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Abstract 
Background: Even though the prevalence of type 2 diabetes mellitus is swelling rapidly in Ethiopia, data regarding 
glycemic control, a key strategy for marked reduction of diabetes mellitus complications, is scant. We have assessed 
the status of glycemic control and its contributing factors among adult patients with type 2 diabetes mellitus.
Methods: This was a facility based cross-sectional survey of 325 adults with type 2 diabetes mellitus attending in 
Jimma University Teaching Hospital, South west Ethiopia. Data from all the patients were collected between Febru-
ary and April 2014. Glycemic level was assessed by using fasting blood glucose level, and ‘poor glycemic control’ was 
defined when fasting blood glucose level was above 130 mg/dL (7 mm/L). Analysis included both descriptive and 
inferential statistics, and SPSS version 20.0 was used for all analysis.
Results: 309 respondents were included in the survey. More than two-third (70.9 %) of the patients had poor blood 
glycemic control. Patients who were illiterate (AOR = 3.46, 95 % CI 1.01–11.91) and farmer (AOR = 2.47, 95 % CI 
1.13–5.39) had high odds of poor glycemic control. In addition, taking combination of insulin and oral medication 
(AOR = 4.59, 95 % CI 1.05–20.14) and poor medication adherence (AOR = 5.08 95 % CI 2.02–12.79) associated statisti-
cally with poor glycemic control.
Conclusion: Majority of patients had poor glycemic control. Patients with low level of education, being employed, 
on combinations of insulin and oral medication, and lower adherence to their medication were likely to have poor 
glycemic control. Education and awareness creation could be a cross cutting intervention for the significant factors.
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Background
Diabetes mellitus (DM) [1] has been ravaging millions 
of people from all over the world. Globally, diabetes has 
killed 4.6 million people in 2013 alone [2]. More than 
77 % of morbidity [3] and 88 % of mortality [4] due to DM 
occur in low- and middle-income countries. In Ethiopia, 
the prevalence of diabetes was 3.5 % in 2011 [5]. Type 2 
diabetes mellitus (T2DM) is the most common form of 
DM, accounting for more than 90  % of cases [2]. Con-
trol of diabetes is more than just taking medicine; other 
aspects of self-management such as self-monitoring of 
blood glucose, dietary restrictions, regular foot care and 
ophthalmic examination have all been shown to mark-
edly reduce the incidence and progression of diabetes 
complications [2]. Previous studies have reported that 
suboptimal glycemic control could cost diabetes patients 
more care requirement, associated health-care costs, and 
loom the complications [6, 7].
The prevalence of poor glycemic control is paramount. 
A study done in Malaysia [8], 2015 showed that 72  % 
of patients had poor glycemic control, and two third of 
DM patients in Ethiopia [9] also had poor control. Pre-
vious studies assured that poor glycemic control cor-
related with enlarged risk of visual impairment [10], 
enlarged risk of kidney failure [11], and enlarged risk 
of cardiovascular disease [12]. In addition, the possible 
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reasons included lack of awareness, time constraint, lack 
of adequate human power, poor adherence, and most 
importantly lack of appropriate guidelines and diabe-
tes education for both care givers and patients [9, 13]. 
Therefore, it is easy to understand that adequate glycemic 
control among T2DM patients prevents short-term com-
plications, decrease the risk of long-term complications, 
and decrease health care resource use and costs [14–16]. 
This figure indicted the need to give an attention for gly-
cemic control. The Healthy People 2020 aimed a 10  % 
reduction in the proportion of DM patients with poor 
glycemic control as a target [17].
But despite the swift growth of prevalence of T2DM in 
Ethiopia, data regarding glycemic control, the key strat-
egy for marked reduction of acute and chronic complica-
tions of DM, is scant. Such data are noteworthy for the 
overall diabetic health care delivery services. We have 
assessed the status of glycemic control and its contribut-
ing factors among adult patients with T2DM.
Methods
Study design, settings and participants
A facility based cross-sectional study was carried out in 
diabetic clinic at Jimma University Teaching Hospital 
(JUTH), Southwest Ethiopia from February 14 to April 
9, 2014. The hospital serves the rural, urban and semi-
urban areas. Drug Administration and Control Authority 
of Ethiopia Contents [18], a guideline similar with Inter-
national Diabetes Federation clinical guideline [3] were 
followed for diagnosis and classification of DM. The study 
was conducted among T2DM adult patients (≥18 years) 
who were on active follow up for at least four visits. The 
required sample size was calculated via OpenEpi soft-
ware using single population proportion calculation for-
mula using the following assumptions: 58.2 % prevalence 
rate of poor glycemic control [19], 95 % confidence level, 
5 % margin of error and 10 % non-response rate. Consid-
ering a correction formula, the total calculated sample 
yielded 325. Using sampling frame of DM records, simple 
random sampling technique was used to recruit the study 
participants (Fig. 1).
Variables of the study and measurement
Glycemic level was the response variable that was coded 
as poor or good. Poor glycemic control was operationally 
defined if fasting blood glucose (FBG) level was above 
130  mg/dl. Patients FBG reading for at least 4  months 
were recorded and computed the mean blood glucose 
level [20]. The explanatory variables included: socio-
demographic and economic data (age, sex, level of edu-
cation, marital status, occupation, income, ethnicity and 
religion), history of smoking, history of alcohol con-
sumption, family history of DM, medication adherence, 
duration of therapy, body mass index (BMI) and number 
of diabetic medication.
Level of education was classified as illiterate (could 
not read and write their local language—‘Afan Oromo’ 
or ‘Amharic’), literate (could read and write but received 
no formal education), primary (received education up to 
class eight), secondary (received education class 9–12), 
and college/university (joined college or university). His-
tory of smoking and history of alcohol consumption has 
been assessed as during lifetime. Family history of DM 
was measured if any family member (mother or father) 
had DM. Morisky adherence score [21], eight-item yes/
no questionnaire, was used to assess the self-reported 
measures of adherence to medications. For all ques-
tions, responses were coded 1 if patients responded ‘yes’ 
otherwise 0 if not, except one question that was coded 
reverse. The total score of adherence was classified into 
low adherence if the score was >2, medium adherence if 
between 1 and 2, and high adherence if 0.
Demographic and clinical characteristics were assessed 
via face-to-face interview and the average glycemic levels 
were reviewed from their chart. To ensure quality of data, 
the tool was developed in English, translated to local lan-
guage (Amharic and Afan-Oromo) and back translated 
into English to check its consistency.
Statistical analysis
Descriptive statistics included mean, median, stand-
ard deviations, and range values for continuous data; 
percentage and frequency tables for categorical data. 
Bivariate logistic regression analysis was conducted to 
see the existence of crude association and select candi-
date variables (with P value below 0.25 were considered) 
Summary of Patient Selection Flow Chart
JUTH diabetic clinic with type-1 and 
type-2 DM (N=2062) 
Patients with type-2 DM (N=1,407) 
Eligible T2DM patients (n=325)  
Data collated from T2DM patients  
(n= 309)
 
655 type-1 DM records 
were excluded 
All T2DM patients 
during study period 
who fulfilled inclusion 
criteria 
16 patient charts were 
not available during 
study period 
Fig. 1 Summary of flowchart record selection, 2014
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to multivariable logistic regression. We checked multi-
collinearity among selected independent variables via 
variance inflation factor (VIF) and none was found. P 
value ≤0.05 was considered as a cut point for statistical 
significance in the final model. Fitness of goodness of the 
final model was checked by Hosmer and Lemeshow and 
was found fit. The Data was summarized using odds ratio 
(OR) and 95 % confidence interval. The analysis was done 
in Statistical Package for the Social Sciences (SPSS) 20 
version software [22].
Ethical considerations
Informed consent was obtained from study participants 
before the commencement of each interview, and no 
personal identification was registered. There was no any 
financial compensation or provision for the study partici-
pants. Permission was obtained from JUSH and the study 
was approved by institutional review board (IRB) of col-
lege of health sciences at Jimma University, Southwest 
Ethiopia.
Results
Socio‑demographic and clinical characteristics 
of respondents
Three hundred and twenty-five DM patients were con-
sidered eligible, whereof 16 were excluded since their 
chart were not available (Fig.  1). In total, 309 patients 
included in the analysis making 95  % response rate. 
Table 1 shows demographic and economic characteristics 
of the respondents. Males were over-represented (61.8 %) 
and almost two-fifth (36.9  %) of the respondents repre-
sented the age group 51–60  years. Nearly half (46.6  %) 
of the respondents followed Muslim religion and four 
out of five (81.2 %) respondents were married. Two fifth 
(36.2 %) respondents attained grades (1–8), and 30.4 % of 
respondents were farmers.
Table  2 shows clinical characteristics of the respond-
ents. Mean BMI of the respondents was 24.4(±4.39) kg/
m2, and 33 % of the respondents had overweight. Great 
majority of the respondents had not access for self-moni-
toring blood glucose (SMBG). About half of the respond-
ents had not get social support, and one fourth (24.6 %) 
of the respondents had family history of DM. The preva-
lence of smoking and alcohol, respectively, was 3 and 5 %. 
DM patients were followed for an average of 7.2 (±5.8) 
years with a minimum of 4  months and a maximum of 
40  years. Diabetic neuropathy was the most common 
DM complication accounting for 41.5 %. Regarding dia-
betic medications, 63.1  % of respondents were taking 
oral medication only followed by insulin (25.6  %). The 
respondents took a mean of 3.66 (±1.60) medications 
ranged between 1 and 7 medications.
Glycemic control level and its contributing factors 
among T2DM patients
Poor glycemic control was seen in 219 (70.9 %) respond-
ents. Age, sex, education, occupation, BMI, anti-diabet-
ics, number of medications and adherence to medication 
were the candidate variables for multiple logistic regres-
sion. The following factors were statistically significant in 
bivariate logistic analysis: being illiterate, being achieved 
grades 1–8, being employed, being farmer, being under 
weight, taking combinations of insulin and oral medica-
tion, taking 2–4 drugs and >4 drugs, medium medication 
adherence and low medication adherence. In multiple 
logistic regression, statistically significant difference was 
found in poor glycemic control to education, occupation, 
anti-diabetics and level of medication adherence.
Table 3 presents the multiple logistic regression analysis 
with demographic and clinical characteristics, and poor 
glycemic control. The association of poor glycemic control 
among illiterate respondents was three times (AOR = 3.46, 
95 % CI 1.01–11.92) greater than among those who were 
in college/university. The relative probability of poor glyce-
mic control among farmers was higher than (AOR = 2.47, 
95  % CI 1.14–5.39) unemployed ones. Compared to 
respondents who took oral medication, respondents 
who took combinations of insulin and oral medication 
were five times (AOR =  4.59, 95 % CI 1.05–20.14) more 
likely to have poor glycemic control. On the other hand, 
the odds of poor glycemic control among patients who 
had medium and low adherence to their medication were 
three (AOR  =  3.49, 95  % CI 1.72–7.09) and five times 
(AOR = 5.08, 95 % CI 2.02–12.79) more than patients who 
had high adherence to their medication respectively.
Discussion
The main goal of diabetes management is to ensure opti-
mal glycemic control. We have assessed the magnitude 
of poor glycemic control and associated factors among 
T2DM patients. Results of this study showed that nearly 
three fourth of patients with T2DM had poor glycemic 
control. This result was comparable to those obtained in 
an earlier study that reported 65 % [23] and 81.9 % [24] 
of respondents had poor glycemic control. This significant 
proportion of poor glycemic control in the country under-
pins the need to work more on self-management strate-
gies of DM patients. The current finding is far higher than 
from developed countries such as 12.9 % in United States 
[7]. This variation could be due to knowledge difference 
of respondents between developing and developed coun-
tries, absence of uniform guidelines in assessing glycemic 
control for physicians to set the score cutoff, and the pres-
ence health insurance and the difference in health insur-
ance coverage and access to primary care [7, 25, 26].
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Significant difference of poor glycemic control was 
observed among illiterates than college/university gradu-
ates. Consistent with this, studies from Jordan [27] and 
China [28] reported the correlation of lower level of 
education and poor glycemic control. This could indi-
cate illiterate patients had low diabetes knowledge, low 
self-management behaviors, lower self-efficacy and 
lower continuity of care. Thus, we are recommending 
investment on getting rid of illiteracy as it has a signifi-
cant impact on the reduction of diabetic morbidity and 
mortality [29, 30]. Poor glycemic control appeared to 
be greater among farmers compared to unemployed 
respondents. This, however, might be due to allocating 
less time for self-management. Majority of the farmers 
in this study were also illiterate compared to unemployed 
respondents implying that farmers might have poor 
awareness of self-care of DM.
It was also likely that the difference in glycemic control 
might result from differences in anti-diabetic treatment. 
Compared to respondents on oral medication, respond-
ents who were on combinations of insulin and oral medi-
cation were five times more likely to have poor glycemic 
control. This association was corroborated by study done 
in Malaysia [31]. The poor control among patients receiv-
ing a combination of insulin and oral anti-diabetic drugs 
shows that multi therapy might challenge satisfactory 
glycemic control. There was a strong inverse associa-
tion between adherence level and poor glycemic control 
as supported by the previous studies [32]. Showing very 
poor outcomes among respondents who fail to comply 
with the prescribed clinical regimen is not surprising 
Table 1 Socio-demographic characteristics of  T2DM 
patients on follow up at JUTH, 2014
a Tigre, Wolayita




Sex Male 189 (61.8)
Female 120 (38.2)
















Educational level Illiterate 87 (28.2)








Occupation Farmer 94 (30.4)
No job 78 (25.2)
Employed 72 (23.3)
Merchant 29 (9.4)
Daily labor 36 (11.7)
Table 2 Clinical characteristics of T2DM patients on follow 
up at JUTH, 2014
Clinical characteristics (n = 309) Category n (%)
Body mass index Under weight 17 (5.5)
Normal weight 161 (52.1)
Over weight 102 (33.0)
Obese 29 (9.4)
Family/social support Yes 175 (56.6)
No 134 (43.4)
Family history Yes 76 (24.6)
No 233 (75.4)
Habit of smoking Smoker 9 (2.9)
Non-smoker 287 (92.9)
Ex-smoker 13 (4.2)
Alcohol drinking Non-drinker 293 (94.8)
Drinker 16 (5.2)




Duration of treatment <5 145 (46.9)
5–10 105 (33.9)
>10 59 (19.2)
Anti-diabetics Insulin 79 (25.6)
Oral medication 195 (63.1)
Insulin & oral medication 35 (11.3)
Diabetic complication (n = 352) Neuropathy 146 (41.5)
Nephropathy 56 (15.9)
Retinopathy 94 (26.7)
Cardiac complications 56 (15.9)
No. of medications <2 drugs 115 (37.2)
2–4 drugs 135 (43.7)
>4 drugs 59 (19.1)
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[33]. Accordingly, counseling and improving adherence 
rather than changing medication or altering the dose has 
been suggested [33]. It is plausible to have an endeavor 
to tackle non-adherence by designing strategies encom-
passing cost, health belief, dosing frequency, personality 
disorders and patient provider relationship.
Worth noting limitations should have noted in this 
study. The use of FBS over HbA1c my under estimate the 
prevalence of poor glycemic control even though FBS 
was found more reliable than HbA1c [34]. The institu-
tional based nature of the study might not infer for other 
diabetic patients. The nature of cross-sectional study 
design does not show temporal relationship or causality. 
Recall bias might also be there during measuring self-
report of medication to adherence.
Conclusion
In summary, the findings from the current study agree in 
many points with the findings of previous publications. 
Significant number of DM patients did not achieve the 
recommended glucose level. This was affected by educa-
tion, occupation, anti-diabetic treatment and adherence 
status of the patients. Education and awareness crea-
tion could be a cross cutting intervention for the signifi-
cant factors. We recommend further population based 
research.
Abbreviations
BMI: body mass index; DM: diabetes mellitus; FBG: fasting blood glucose; 
HbA1c: glycosylated hemoglobin; IDFA: International Diabetes Federation 
Atlas; JUSH: Jimma University Specialized Hospital; OHA: oral hypoglycemic 
agent; SMBG: self-monitoring blood glucose; SDSCA: summary of diabetes 
self-care activities; T2DM: type-2 diabetes mellitus.
Authors’ contributions
TK involved in designing of the study, data collection, data analysis, drafting 
and critically reviewing the manuscript. Likewise, TE and HG involved in 
designing of the study, analysis of the data and critically reviewing the manu-
script. All authors read and approved the final manuscript.
Author details
1 Dilchora Hospital, Dire Dawa, East Ethiopia. 2 Department of Clinical Phar-
macy, College of Health Sciences, Jimma University, Jimma,  Ethiopia. 3 Depart-
ment of Epidemiology, College of Health Sciences, Jimma University, Jimma, 
Ethiopia. 4 Discipline of Public Health, Faculty of Medicine, Nursing and Health 
Sciences, Flinders University, Adelaide, Australia. 
Acknowledgements
The authors are grateful to the data collectors who gathered the data. This 
research was funded by Jimma University.
Competing interests
The authors declare that they have no competing interest. This research was 
funded by Jimma University. The funders had no role in study design, data col-
lection and analysis, decision to publish, or preparation of the manuscript.
Received: 19 November 2015   Accepted: 31 January 2016
Table 3 Factors independently associated with poor glycemic level among T2DM patients JUTH, 2014
a Statistically significant at P value <0.05
Variables (n = 309) Glycemic level Crude OR (95 % CI) Adjusted OR (95 % CI) P value
Good, n (%) Poor, n (%)
Education
 Illiterate 18 (20.7 %) 69 (79.3 %) 2.65 (1.20–5.87)a 3.46 (1.01–11.91) 0.049a
 Read & write 10 (45.5 %) 12 (54.5 %) 0.83 (0.29–2.33) 0.81 (0.20–3.26) 0.766
 1–8 31 (27.7 %) 81 (72.3 %) 1.81 (0.87–3.75) 2.45 (0.85–7.03) 0.095
 9–12 13 (29.5 %) 31 (70.5 %) 1.65 (0.68–3.99) 1.97 (0.69–5.55) 0.202
College/University 18 (40.9 %) 26 (59.1 %) 1 1
 Occupation
 No job 31 (39.7 %) 47 (60.3 %) 1 1
 Employed 21 (29.2 %) 51 (70.8 %) 1.60 (0.81–3.16) 2.65 (0.96–7.24) 0.048a
 Merchant 6 (20.7 %) 23 (79.3 %) 2.53 (0.92–6.91) 2.69 (0.86–8.37) 0.086
 Farmer 19 (20.2 %) 75 (79.8 %) 2.60 (1.32–5.12)a 2.47 (1.13–5.39) 0.023a
 Daily labor 13 (36.1 %) 23 (63.9 %) 1.17 (0.51–2.64) 2.22 (0.80–6.11) 0.124
Anti-diabetics
 Insulin 21 (26.6 %) 58 (73.4 %) 1.38 (0.77–2.47) 1.77 (0.60–5.19) 0.298
 Oral medication 65 (33.3 %) 130 (66.7 %) 1 1
 Insulin and oral medication 4 (11.4 %) 31 (88.6 %) 3.88 (1.31–11.45)a 4.59 (1.05–20.14) 0.043a
Medication adherence
 High 52 (45.2 %) 63 (54.8 %) 1 1
 Medium 25 (21.4 %) 92 (78.6 %) 3.04 (1.71–5.43)a 3.49 (1.72–7.09) 0.001a
 Low 13 (16.9 %) 64 (83.1 %) 4.06 (2.02–8.18)a 5.08 (2.02–12.79) 0.001a
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